The Evidence in Allergy Group, led by Dr. Derek Chu at McMaster University, in partnership with the Joint Task Force on Practice Parameters, comprised of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), is developing an evidence-based guideline addressing the management of severe asthma.

We are currently seeking patient or caregiver partners to share their experience with severe asthma and help shape the future of asthma care through updated, evidence-based, trustworthy guidelines. As a patient or caregiver partner, there are two potential levels of engagement. In the first, you could engage in surveys about outcomes that matter to you, and about your values and preferences related to asthma treatment. The anticipated commitment would be about 1 hour and interaction virtually.  The second level of engagement entails acting as a panel member by interpreting data and formulating treatment recommendations with the rest of the guideline panel. The anticipated commitment would be about 30 hours and interaction virtually. Participating patient or caregiver partners who complete all required steps in participation will be offered an honorarium of 100 USD and those participating as panel members will be offered an honorarium of 1000 USD.

If you are interested, please complete the following interest form: https://forms.gle/6nrPeKVsGs9QQM4d9. An expression of interest does not guarantee selection. If you have any questions, please email allergyevidence@gmail.com.